Scopus
🔓 Açık Erişim YÖKSİS ISSN Eşleşti
SJR Q2
What are the drugs having potential against COVID-19?
Medicinal Chemistry Research · Kasım 2020
Özet
A disease emerged in the city of Wuhan, Hubei Province, Central China in the last month of 2019. It was pneumonia caused by a newly emerged coronavirus called COVID-19, later. Coronaviruses are enveloped RNA viruses belong to the Betacoronavirus family and infected birds, humans, and other mammals. In March 2020, the World Health Organization declared the COVID-19 outbreak could be characterized as a global pandemic because the disease spread, and a large number of people were infected and died in many countries on different continents by virtue of this new virus. Now, intensive work is underway about the pathogenic mechanisms and epidemiological properties of COVID-19, and a great effort is made to develop effective specific therapeutic drugs, vaccines, and/or treatment strategies against these diseases. Herein, we have focused on all treatment options available against COVID-19 pneumonia in this text.
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 9 kaydı bulundu.
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 9 kaydı bulundu.
Genotoxic potentials and eukaryotic DNA topoisomerase I inhibitory effects of some benzoxazine derivatives
2014 ISSN: 1054-2523 SCI-Expanded
Dr. Öğr. Üyesi FATMA ZİLİFDAR FOTO →
Cytotoxicities of novel hydrazone compounds with pyrrolidine moiety: inhibition of mitochondrial respiration may be a possible mechanism of action for the cytotoxicity of new hydrazones
2018 ISSN: 1054-2523 SCI
Prof. Dr. KAAN KÜÇÜKOĞLU →
Synthesis and evaluation of anticancer effect of a novel molecule based-on pillar[5]arene including multi quinoline units
2020 ISSN: 1054-2523 SCI-Expanded Q4
Prof. Dr. MUSTAFA ÖZMEN →
What are the drugs having potential against COVID-19?
2020 ISSN: 1054-2523 SCI-Expanded
Prof. Dr. KAAN KÜÇÜKOĞLU →
What are the drugs having potential against COVID-19?
2020 ISSN: 10542523 SCI
Dr. Öğr. Üyesi NAGİHAN FAYDALI →
Synthesis of new calix[4]arene derivatives and evaluation of their cytotoxic activity
2022 ISSN: 1054-2523 SCI-Expanded Q4
Doç. Dr. MEHMET OĞUZ →
Synthesis of new calix[4]arene derivatives and evaluation of their cytotoxic activity
2022 ISSN: 1054-2523 SCI Q4
Prof. Dr. MUSTAFA YILMAZ →
Design, Synthesis and Molecular Docking Studies of Novel Benzimidazole-1,3,4-oxadiazole Hybrids for Their Carbonic Anhydrase Inhibitory and Antioxidant Effects
2022 ISSN: 1054-2523 SCI-Expanded
Prof. Dr. KAAN KÜÇÜKOĞLU →
Synthesis of new calix[4]arene derivatives and evaluation of their cytotoxic activity
2022 ISSN: 1054-2523 SCI
Prof. Dr. SERDAR KARAKURT →
Makale Bilgileri
Toplam Atıf
7 atıf
· Scopus
ISSN10542523
Yayın TarihiKasım 2020
Cilt / Sayfa29 · 1935-1955
Scopus ID2-s2.0-85091072937
Erişim🔓 Açık Erişim
Kurumlar
Selçuk Üniversitesi
Selçuklu Turkey
Havuzumuzdaki Atıflar 0
Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 7.
Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi (ISSN Eşleşmesi)
Medicinal Chemistry Research
Q2
SJR Skoru0,501
H-Index69
YayıncıSpringer
ÜlkeUnited States
Organic Chemistry (Q2)
Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
Metrikler
7
Atıf